title: Ustekinumab as a Therapeutic Option for Children With Refractory Enthesitis-Related Arthritis.
authors.affiliation: Department of Pediatrics University of Alabama at Birmingham Birmingham, AL mstoll@peds.uab.edu.
authors.forename: Melissa L
authors.initials: ML
authors.lastname: Mannion
authors.forename: Linda
authors.initials: L
authors.lastname: McAllister
authors.forename: Randy Q
authors.initials: RQ
authors.lastname: Cron
authors.forename: Matthew L
authors.initials: ML
authors.lastname: Stoll
mesh_terms: D000293:Adolescent; D018501:Antirheumatic Agents / Q000008:administration & dosage; D001171:Arthritis, Juvenile / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D016903:Drug Monitoring / Q000379:methods; D018432:Drug Resistance, Multiple; D005260:Female; D006801:Humans; D018664:Interleukin-12 / Q000037:antagonists & inhibitors; D053759:Interleukin-23 / Q000037:antagonists & inhibitors; D008297:Male; D062072:Patient Acuity; D063189:Symptom Assessment / Q000379:methods; D016896:Treatment Outcome; D000069549:Ustekinumab / Q000008:administration & dosage*
chemical_list: D018501:Antirheumatic Agents; D053759:Interleukin-23; D018664:Interleukin-12; D000069549:Ustekinumab